BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24228874)

  • 1. Regulation of activity of transcription factor NF-κB by synthetic oligonucleotides.
    Metelev VG; Kubareva EA; Oretskaya TS
    Biochemistry (Mosc); 2013 Aug; 78(8):867-78. PubMed ID: 24228874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of NF-kappaB involved in osteoblast development through interleukin-6.
    Deyama Y; Takeyama S; Suzuki K; Yoshimura Y; Nishikata M; Matsumoto A
    Biochem Biophys Res Commun; 2001 Apr; 282(5):1080-4. PubMed ID: 11302724
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of NF-kappaB oligonucleotide "decoys" on gene expression in P7 rat hippocampus after hypoxia/ischemia.
    Qiu J; Hu X; Nesic O; Grafe MR; Rassin DK; Wood TG; Perez-Polo JR
    J Neurosci Res; 2004 Jul; 77(1):108-18. PubMed ID: 15197744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of synthetic oligonucleotides for inhibition of factor NF-kappa B].
    Kozlov IA; Kubareva EA; Shabarova ZA
    Mol Biol (Mosk); 1998; 32(3):389-400. PubMed ID: 9720060
    [No Abstract]   [Full Text] [Related]  

  • 5. Regulation of monocyte chemoattractant protein-1 by the oxidized lipid, 13-hydroperoxyoctadecadienoic acid, in vascular smooth muscle cells via nuclear factor-kappa B (NF-kappa B).
    Dwarakanath RS; Sahar S; Reddy MA; Castanotto D; Rossi JJ; Natarajan R
    J Mol Cell Cardiol; 2004 Apr; 36(4):585-95. PubMed ID: 15081318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein 70 confers cardiovascular protection during endotoxemia via inhibition of nuclear factor-kappaB activation and inducible nitric oxide synthase expression in the rostral ventrolateral medulla.
    Chan JY; Ou CC; Wang LL; Chan SH
    Circulation; 2004 Dec; 110(23):3560-6. PubMed ID: 15557375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent biphasic induction and transcriptional activity of nuclear factor kappa B (NF-kappaB) in EA.hy.926 endothelial cells after low-dose X-irradiation.
    Rödel F; Hantschel M; Hildebrandt G; Schultze-Mosgau S; Rödel C; Herrmann M; Sauer R; Voll RE
    Int J Radiat Biol; 2004 Feb; 80(2):115-23. PubMed ID: 15164793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antisense evidence for nuclear factor-kappaB-dependent embryopathies initiated by phenytoin-enhanced oxidative stress.
    Kennedy JC; Memet S; Wells PG
    Mol Pharmacol; 2004 Sep; 66(3):404-12. PubMed ID: 15322231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of adjuvant arthritis using microencapsulated antisense NF-κB oligonucleotides.
    Akhavein N; Oettinger CW; Gayakwad SG; Addo RT; Bejugam NK; Bauer JD; Do D; Pollock SH; D'souza MJ
    J Microencapsul; 2009 May; 26(3):223-34. PubMed ID: 18666015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The NF-kappaB transcription factor in oncogenesis.
    Sharma HW; Narayanan R
    Anticancer Res; 1996; 16(2):589-96. PubMed ID: 8687102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidized ultrashort nanotubes as carbon scaffolds for the construction of cell-penetrating NF-kappaB decoy molecules.
    Crinelli R; Carloni E; Menotta M; Giacomini E; Bianchi M; Ambrosi G; Giorgi L; Magnani M
    ACS Nano; 2010 May; 4(5):2791-803. PubMed ID: 20411956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Local administration of transcription factor decoy oligonucleotides to nuclear factor-kappaB prevents carrageenin-induced inflammation in rat hind paw.
    D'Acquisto F; Ialenti A; Ianaro A; Di Vaio R; Carnuccio R
    Gene Ther; 2000 Oct; 7(20):1731-7. PubMed ID: 11083494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A biophysical characterisation of factors controlling dimerisation and selectivity in the NF-kappaB and NFAT families.
    de Lumley M; Hart DJ; Cooper MA; Symeonides S; Blackburn JM
    J Mol Biol; 2004 Jun; 339(5):1059-75. PubMed ID: 15178248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcription factor decoy approach to decipher the role of NF-kappa B in oncogenesis.
    Sharma HW; Perez JR; Higgins-Sochaski K; Hsiao R; Narayanan R
    Anticancer Res; 1996; 16(1):61-9. PubMed ID: 8615671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of stably transfected Mammalian cell lines as fluorescent screening assay for NF-kappaB activation-dependent gene expression.
    Hellweg CE; Baumstark-Khan C; Horneck G
    J Biomol Screen; 2003 Oct; 8(5):511-21. PubMed ID: 14567778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of p65 NF-kappaB protein by p210BCR-ABL in a myeloid cell line (P210BCR-ABL activates p65 NF-kappaB).
    Hamdane M; David-Cordonnier MH; D'Halluin JC
    Oncogene; 1997 Nov; 15(19):2267-75. PubMed ID: 9393872
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NF-κB cellular and molecular regulatory mechanisms and pathways: therapeutic pattern or pseudoregulation?
    Haddad JJ; Abdel-Karim NE
    Cell Immunol; 2011; 271(1):5-14. PubMed ID: 21777910
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of nuclear factor-kappa B p65 antisense oligonucleotides on expression of proinflammatory cytokines in lamina propria mononuclear cells from patients with ulcerative colitis].
    Gan H; Ouyang Q; Chen Y; Liang F
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2003 Jun; 20(2):268-72. PubMed ID: 12856595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NF-kappaB as a potential therapeutic target in osteoarthritis and rheumatoid arthritis.
    Roman-Blas JA; Jimenez SA
    Osteoarthritis Cartilage; 2006 Sep; 14(9):839-48. PubMed ID: 16730463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Up-regulation of histamine H4 receptors contributes to splenic apoptosis in septic mice: counteraction of the antiapoptotic action of nuclear factor-kappaB.
    Matsuda N; Teramae H; Futatsugi M; Takano K; Yamamoto S; Tomita K; Suzuki T; Yokoo H; Koike K; Hattori Y
    J Pharmacol Exp Ther; 2010 Mar; 332(3):730-7. PubMed ID: 20008488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.